MJBizDaily
FDA approved cannabis: Why Schedule 3 means operators must prepare for pharmaceutical-grade MMJ now
Featured
Latest Posts
Can the $28 billion hemp industry be saved?
With a looming federal ban that could shut down the industry, Lackner is pushing for regulations and a two-year extension of the deadline.
News April 9
Are state bans on hemp THC constitutional?
Hemp operators are using constitutional challenges to unwind state-level bans on hemp-derived THC products.
News April 8
Massachusetts cannabis law revamp could double MSO retail footprint
The bill also would remove the rule that forced medical marijuana businesses to grow, process and sell all their own products.
News April 8
The secret for successful cannabis retailers: it’s not the purchase, it’s the experience
Cannabis retailers are boosting revenue by providing more than just a transaction for customers visiting their stores.
News April 8
Cannabis consumers don’t want low-dose THC beverages, California companies claim
Cannabis beverages with small amounts of THC, such as 10 milligrams and less, aren't popular with California consumers, according to a letter to state lawmakers.
News April 7
Report: North Carolina illicit cannabis market is worth $3 billion
By transitioning consumers to a regulated framework, North Carolina could capture substantial economic benefits.
News April 7
Can the right data convince banks to lend to cannabis operators?
The NCS Thea platform acts as a bridge between cautious financial institutions and capital-starved cannabis businesses.
News April 7
New York cannabis retailers averaging about $4 million in annual sales
New York cannabis retailers are averaging about $4 million in annual sales after a year in business, state regulators said.
News April 6
Two more marijuana MSOs enter Texas medical cannabis market
Texas authorities awarded three more vertically integrated medical cannabis permits, and marijuana multistate operators snagged two.
News April 6
Latest Sponsored
